Navigation Links
Takeda Type 2 Diabetes Therapies, NESINA (alogliptin), KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone) Now Available in Pharmacies in the United States
Date:6/17/2013

patients treated with co-administration of alogliptin and pioglitazone) were nasopharyngitis (4.9%), back pain (4.2%), and upper respiratory tract infection (4.1%).

Drug Interactions

Use of OSENI with CYP2C8 strong inhibitors (e.g., gemfibrozil) will, or inducers (e.g., rifampin) may, require dose adjustment.

Cationic drugs eliminated by renal tubular secretion should be used with caution if taken with KAZANO.

Please see accompanying Full Prescribing Information, including Medication Guide, for NESINA.

Please see accompanying Full Prescribing Information, including Medication Guide, for KAZANO.

Please see accompanying Full Prescribing Information, including Medication Guide, for OSENI.

Takeda Pharmace
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Major hurdle cleared to diabetes transplants
2. hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Introduces Improved hCG Diets to Help Patients Achieve Best Weight Loss Goals and Reduce the Symptoms of Diabetes
3. Nationwide Children’s Hospital Develops First Pediatric-Focused Diabetes Calculator
4. Woman Was Able to Stop the Development of Diabetes in a Personalized Prediabetes Treatment Program
5. Moderate-intensity walking timed just right might help protect against Type 2 diabetes
6. Diabetes drug points the way to overcoming drug resistance in melanoma
7. Genetic studies lead to clinical trial of new treatment for type 1 diabetes
8. The diabetes breathalyzer
9. Investigation into safety of new diabetes drugs -- will manufacturers release their data?
10. Pathogen-Free Pigs Valued At $350,000 Each Offer Hope To People With Type 1 Diabetes
11. FDA Panel Votes to Change Tight Restrictions on Diabetes Drug Avandia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... of California, San Diego School of Medicine report that ... a recent major loss are more likely to be ... study is published in this month,s issue of the ... compassionate behaviors are associated with better health and well-being ... ways to improve the outcomes of individuals whose deficits ...
(Date:4/17/2014)... In a review published in the April issue ... of The Feinstein Institute for Medical Research, says it,s ... community,s approach to treating sepsis, which kills ... , Sepsis occurs when molecules released into the bloodstream ... the body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... NEW YORK, NY (April 16, 2014) The cause ... but a new study proposes that neurons may be ... own immune system, similar to the way autoimmune diseases ... attack the body,s cells. The study was published April ... is a new, and likely controversial, idea in Parkinson,s ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
... , WASHINGTON , Jan. 15 ... with 22 national organizations, attended the first consortium meeting ... initiative to improve lupus diagnosis, treatment, and management among ... Rheumatology offices in Atlanta, Georgia from January ...
... FRANCISCO , Jan. 15 A Good Idea , a ... San Francisco , plans to give $100,000 to Haiti ... Community Giving contest sponsored by JPMorgan Chase & Co. , "While ... Bay Area, we feel that it is of the utmost importance to contribute ...
... , SANTA BARBARA, Calif. , Jan. 15 ... connecting essential micronutrients, especially vitamin A, with infants and children ... a disaster relief agency, Vitamin Angels has responded to ... Haiti , by shipping over 1 million children,s multivitamins. After ...
... , PHOENIX , Jan. 15 ... rice bran (SRB) nutrient research and technology, today announced a 17% ... to improve the company,s cost structure. The reduction, which is anticipated ... impact the workforce at Irgovel, NutraCea,s Brazilian subsidiary. , W. ...
... , OCEANSIDE, Calif. , Jan. 15 ... organizations that work with teens are tirelessly launching grassroots efforts to ... In many cities, the efforts are led by teens themselves. , ... cannot change the world.  But the people who see it can ...
... , Jan. 15 The March of Dimes has ... mothers and babies in Haiti imperiled by the devastating ... concerned about the thousands of pregnant women and moms caring for ... Dr. Jennifer L. Howse , president of the March of ...
Cached Medicine News:Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 2Health News:Lupus Foundation of America Collaborates with Federal Agencies and the U.S. Surgeon General's Office to Expand Medical Education on Lupus 3Health News:San Francisco Charity A GOOD IDEA to Give $100,000 to Haiti Victims Upon Winning Nationwide Charity Program 2Health News:Vitamin Angels Responds to Haiti Disaster 2Health News:NutraCea Announces Reduction in Workforce in U.S. Operations 2Health News:Movie Turns Into a Growing Movement to Reach Hurting Teens. 2Health News:Movie Turns Into a Growing Movement to Reach Hurting Teens. 3Health News:Movie Turns Into a Growing Movement to Reach Hurting Teens. 4Health News:Movie Turns Into a Growing Movement to Reach Hurting Teens. 5Health News:March of Dimes Supports Urgent Needs of Mothers and Babies in Haiti Earthquake 2
(Date:1/14/2014)... , Jan. 14, 2014 HeartWare International, ... innovator of less invasive, miniaturized circulatory support technologies that ... announced that it expects revenues for the fourth quarter ... full-year 2013 revenues to approximately $208 million. ...
(Date:1/14/2014)... North America,s leading business partnering event ... 30 th edition of its annual conference at the ... 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... specialty chemical companies will take part in the conference, which ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ("DHS"), ... that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") of ... The terms of the acquisition were not disclosed. ... company providing a wide range of sleep, mobility, and respiratory ...
Breaking Medicine Technology:HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3
... REMICADE Therapy is More Likely to Induce Steroid-Free Remission ... ... Data presented for the first time,from the Phase 3b Study ... may provide new insights into,the approach to care of patients with ...
... More than 60 percent of moderate to severe ... achieved endoscopic remission at Week 10,in data from ... College,of Gastroenterology (ACG) Annual Scientific Meeting, ORLANDO, ... from a,large, prospective study investigating endoscopic improvement in ...
Cached Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7
... grafting or creation of a vascular access, ... is of the utmost importance in many ... for those seeking a high-precision tunneling instrument. ... risk of twisting or kinking for more ...
... Stretch Vascular Grafts have met the ... procedures. Recognized for exceptional performance and ... of renowned surgeons worldwide. These grafts ... the spread of infection, and ensure ...
... Today's evolving techniques for vascular surgery, ... require that new, specialized types of graft ... strong, inert and biocompatible, but also available ... vascular access. GORE-TEX Vascular Graft has long ...
... INTERING Vascular Graft, the newest vascular graft ... a leader in vascular surgical products for ... by reducing kinking and compression problems ... new graft provides all of the benefits ...
Medicine Products: